BIOPHARM-SELTEK NEGOTIATION 2
Biopharm-Seltek Negotiation Reflection
I was the CFO of Biopharm in the case simulation. After our negotiations, the CEO of
Seltek and I settled on a price of $12.2 million. Looking back on the negotiations, I was able to
secure a good deal for Biopharm within a relatively short time. I initially expected that it would
take tremendous periods of intense negotiations but we were able to conclude negotiations fast
enough, and this was a positive thing for me.
I believe that one thing that aided the negotiation was a clear understanding about both
organizations, and setting a clear reservation price. It was critical for both of us to have
information on each other’s company. Thus, we were both clear about what to expect from one
another and these expectations were fulfilled. Not only was I aware of my reservation price, I
also had a rough estimate of Seltek’s reservation price. My initial target price was $15 million,
but I did not move to make the first offer. Making the first offer usually has the advantage of
providing the offerer with anchoring bias. Nonetheless, I opted not to provide the first offer since
I felt I had the advantage of a good knowledge base. Knowledge is also significant in
negotiations as it provides power. In this case, allowing the Seltek CEO to make the first offer
provided an opportunity to see how they positioned the company and assess this against my own
expectations. My decision paid off since I received an offer that was below my target price. This
allowed me to readjust and make a counteroffer.
I believe that the lower initial offer is what contributed to the quick resolution of the
negotiations. Indeed, I was tempted to accept this offer but I was aware that accepting the first
offer might leave my partner with regret. I had initially adopted a competitive approach but a
realigned it to a more integrative one. We began to work through the issues at hand, which
allowed us to focus less on the issue of money and more on intangibles. I think I felt that I had